Supplementary Table S9 from Safety and Efficacy of Eflornithine in Patients with Gastric Precancerous Lesions: A Double-Blinded, Randomized Clinical Trial
Authors:
- Douglas R. MorganDMDouglas R. Morgan
- Ricardo L. DominguezRDRicardo L. Dominguez
- Dalton A. NorwoodDNDalton A. Norwood
- Eleazar E. Montalvan-SanchezEMEleazar E. Montalvan-Sanchez
- M. Blanca PiazueloMPM. Blanca Piazuelo
- Aida Rodriguez-MurilloARAida Rodriguez-Murillo
- Alberto G. DelgadoADAlberto G. Delgado
- Jessica Hernandez-MarreroJHJessica Hernandez-Marrero
- Maria Gonzalez-PonsMGMaria Gonzalez-Pons
- T. Mark BeasleyTBT. Mark Beasley
- Marcia Cruz-CorreaMCMarcia Cruz-Correa
- Keith T. WilsonKWKeith T. Wilson
Open Access
- 1 July 2026
- other
- Published by American Association for Cancer Research (AACR)